Bayer, Merck Hit In Pa. Court Over Avelox Nerve Damage
Bayer Corp. and Merck & Co. Inc. downplayed the risk of permanent nerve damage posed by the antibiotic Avelox and have promoted the drug for minor conditions that can be treated...To view the full article, register now.
Already a subscriber? Click here to view full article